Denver Lough, MD, PHD

President, Chief Executive Officer & Chairman, PolarityTE

Denver Lough, MD, PHD

Dr. Denver Lough has always sought to investigate reality, pursue complex simplicity and develop a new paradigm in translational science. He is the President, Chief Executive Officer and Chairman of PolarityTE, and discoverer of micro-aggregate cell-based technologies for applications in the regeneration of functionally-polarized tissues. A prior member of the Johns Hopkins Plastic and Reconstructive Surgery Residency Program, Dr. Lough’s interests surround pragmatic tissue engineering, deployable regenerative material constructs, real-time assessment of cell-to-tissue fate, reactivity, functionality and, ultimately, therapeutic efficacy in complex living systems. Dr. Lough has significant experience with bench-to-bedside translational applications from assays/equipment to IRB/clinical trial development to scientific writing and presenting. He is well-respected within the field by thought leaders, with numerous national awards and accolades, as well as the ability to access a wide variety of clinical and research networks and markets. Dr. Lough holds an MD and PhD in Biochemistry, Molecular and Cell Biology from Georgetown University and was a Senior Plastic Surgery Resident at Johns Hopkins before leaving his position to start PolarityTE.